Proteus Biomedical, Inc. announced that it expects to receive $50 million in funding from Essex Woodlands Health Ventures, Kaiser Permanente Ventures, and other investors.

Proteus Biomedical, Inc. announced that it will raise $50,000,000 in an equity round of funding on May 1, 2012. The securities will be issued pursuant to Regulation D. On the same day, the company raised $17,500,000 from three investors including lead investors Essex Woodlands Health Ventures and Kaiser Permanente Ventures.